Processing

Please wait...

Settings

Settings

Goto Application

1. WO2006097732 - TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES

Publication Number WO/2006/097732
Publication Date 21.09.2006
International Application No. PCT/GB2006/000945
International Filing Date 16.03.2006
IPC
C07K 14/47 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
A61K 38/17 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
Applicants
  • ANAMAR MEDICAL AB [SE]/[SE] (AllExceptUS)
  • WEBBER, Philip, Michael [GB]/[GB] (MN)
  • SJÖBERG, Andreas [SE]/[SE] (UsOnly)
  • BLOM, Anna [SE]/[SE] (UsOnly)
  • HEINEGARD, Dick [SE]/[SE] (UsOnly)
Inventors
  • SJÖBERG, Andreas
  • BLOM, Anna
  • HEINEGARD, Dick
Agents
  • FRANK B. DEHN & CO.
Priority Data
0505641.118.03.2005GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
(FR) TRAITEMENT DE MALADIES AUTO-IMMUNES ET INFLAMMATOIRES
Abstract
(EN)
The present invention relates to isolated polypeptides which are capable of inhibiting the activation of the complement system and the use of such polypeptides for the treatment of autoimmune and/or inflammatory diseases such as rheumatoid arthritis, osteoarthritis, atherosclerosis, respiratory distress syndrome, obstructive lung disease, glomerulonephritis, ischemia/reperfusion injury or multiple sclerosis. Preferably, the isolated peptides are fragments of fibromodulin.
(FR)
La présente invention concerne des polypeptides isolés qui sont capables d'inhiber l'activation du système du complément et l'utilisation de ces polypeptides pour le traitement de maladies auto-immunes et/ou inflammatoires, telles que la polyarthrite rhumatoïde, l'arthrose, l'athérosclérose, le syndrome respiratoire aigu sévère, la maladie respiratoire obstructive, la glomérulonéphrite, l'ischémie/lésion de reperfusion ou la sclérose en plaques. De préférence, les peptides isolés sont des fragments de la fibromoduline.
Also published as
EP6710107
Latest bibliographic data on file with the International Bureau